Parenterally fed preterm neonates are known to be at risk for carnitine deficiency.
Subjects and methods

Subjects
or no effects (3, 5) in the carnitine-supplemented group. These previous studies are not quite comparable with ours, because all other studies were performed by using an intravenous lipid-tolerance test during which lipids were infused at a relatively high rate over a short time. This is not representative ofthe normal clinical situation because it is advised that fat emulsions should be infused continuously (2 1). Furthermore, in all but one study (5) lower dosages of carnitine were used.
Multiple-regression analysis indicates that carnitine supple-TABLE 2 Levels offree-, acyl-, and total carnitine and acyl-free ratio in plasma at day 7 in infants without (A) and with (B) L-carnitine Once it is known that carnitine may increase nitrogen excretion, the beneficial effects of the increased fat oxidation that can be attained by this dosage of carnitine must be weighed carefully.
In the patient group studied here, intolerance of intravenous fat emulsions is not an important issue: the children 
55.
a' a, 
